AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Other Versions of this Article:
AAC.00569-06v1
50/11/3929    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, T. J.
Right arrow Articles by Nolan, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, T. J.
Right arrow Articles by Nolan, L. K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2006, p. 3929-3933, Vol. 50, No. 11
0066-4804/06/$08.00+0     doi:10.1128/AAC.00569-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Complete DNA Sequence, Comparative Genomics, and Prevalence of an IncHI2 Plasmid Occurring among Extraintestinal Pathogenic Escherichia coli Isolates {triangledown},{dagger}

Timothy J. Johnson, Yvonne M. Wannemeuhler, Jennifer A. Scaccianoce, Sara J. Johnson, and Lisa K. Nolan*

Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, 1802 Elwood Drive, VMRI 2, Iowa State University, Ames, Iowa 50011

Received 8 May 2006/ Returned for modification 6 July 2006/ Accepted 14 August 2006


   ABSTRACT
Top
 Abstract
Text
 References
 
We have sequenced a large plasmid that occurs among avian pathogenic Escherichia coli isolates. This plasmid, pAPEC-O1-R, is a 241,387-bp IncHI2 plasmid which is cotransmissible via bacterial conjugation with a ColBM virulence plasmid, encodes resistance to eight antimicrobial agents, and appears to occur at low rates among extraintestinal E. coli isolates.


   TEXT
Top
 Abstract
 Text
References
 
Extraintestinal pathogenic Escherichia coli (ExPEC) organisms cause significant disease in both humans and animals. Large plasmids are often a part of the ExPEC genome (8, 9, 10, 14). However, these plasmids are underrepresented in the sequence database; and such sequences are necessary to better understand their roles in virulence, resistance, and horizontal gene transfer (5). No complete sequences of IncH plasmids from E. coli are available, although such plasmids are well described in other organisms (6, 16). The only fully sequenced IncHI2 plasmid, R478, was isolated from Serratia marcescens in the United States in 1969 (11). Here, we present the first complete sequence of an IncHI2 plasmid from an E. coli isolate, and we describe the use of comparative genomics to further define the backbone components of IncHI2 plasmids and to explore their evolution. Additionally, the prevalence of the genes of IncHI2 plasmids and the resistance that they encode are determined for a broad collection of ExPEC and commensal E. coli isolates in order to evaluate their host range and impact.

Overview of pAPEC-O1-R. Approximately 3,000 sequencing reads from the genomic library of avian pathogenic E. coli (APEC) O1 were used to assemble the complete sequence of pAPEC-O1-R at approximately ninefold coverage. The closed, circular plasmid had a size of 241,387 bp (Fig. 1). The overall G+C content of pAPEC-O1-R was 46.3%. Analysis of the sequence revealed 225 open reading frames (ORFs) (see the supplemental material). Of the ORFs identified, 15 (6.7%) were classified as hypothetical proteins with no matches in the nonredundant database, 94 (41.8%) were classified as conserved hypothetical proteins with matches to proteins of unknown function, 34 (15.1%) were identified as plasmid transfer proteins, 33 (14.7%) were matched with antimicrobial resistance proteins, and 17 (7.6%) were matched with mobile genetic elements.


Figure 1
View larger version (40K):
[in this window]
[in a new window]
  		FIG. 1. Map of pAPEC-O1-R. The outer two circles show ORFs in the forward and the reverse orientations, respectively. Colors correspond to the following: blue, plasmid transfer; red, replication, olive, unknown function; yellow, mobile genetic elements; orange, tellurite resistance; pink, copper resistance; black, silver resistance; green, class 1 integron; light green, plasmid maintenance; light blue, cell metabolism. The third circle shows a scale (in base pairs). The fourth circle shows the G+C content plotted against the average G+C content for the plasmid of 49.6% (purple). The fifth circle plots the G+C skew in a 500-bp sliding window (blue). IS elements are depicted inside the fifth circle. The map was created by using GenVision from DNASTAR.

 
The transmissibility of pAPEC-O1-R was confirmed by mating APEC O1 with E. coli DH5{alpha}, a plasmidless recipient strain (15), and transconjugants were produced at a rate of approximately 5 x 10–5 transconjugants/donor at 25°C.

Comparative genomics. In an effort to better define the IncH plasmid backbone, pAPEC-O1-R was compared to the only other fully sequenced IncHI2 plasmid, pR478, and its close relatives, Salmonella enterica subsp. enterica serovar Typhi strain CT18 plasmid pHCM1 and Salmonella serovar Typhi plasmid R27 (13, 16). Comparison of the nucleotide sequences of pR478 and pAPEC-O1-R revealed that they were extremely similar to one another (Fig. 2). Regions common to pR478 and pAPEC-O1-R, which might define the IncHI2 backbone, included the Tra1 and Tra2 transfer regions; the copper, silver, and tellurite resistance regions; and the IncHI2 replicon (7). The DNA not common to both plasmids included insertion sequence (IS) elements, different class 1 integrons in both plasmids, and the arsenic and mercury resistance regions in pR478. If, as suggested previously (6), IncH plasmid evolution is mediated by a series of acquisition events, these two plasmids are likely derived from a common ancestor that had the core "backbone" components described above.


Figure 2
View larger version (34K):
[in this window]
[in a new window]
  		FIG. 2. Four-way nucleotide comparison of pAPEC-O1-R with pR27 (n = 33), pR478 (n = 11), and pHCM1 (n = 26). Light purple rays, direct nucleotide homology at a cutoff value of 50%; dark purple rays, inverted nucleotide homology. Colored blocks correspond to the following regions: red, Tra2 region; orange, tellurite resistance region; dark green, class 1 integron unique to pAPEC-O1-R; light green, copper and silver resistance regions; yellow, Tra1 region; pink; arsenic resistance region of pR478; and blue, IncHI2 replicon and adjacent regions.

 
A four-way comparison of pAPEC-O1-R, pR478, and IncHI1 plasmids pHCM1 and pR27 revealed that pR27 and pHCM1 shared much less nucleotide sequence homology to pAPEC-O1-R than they did to pR478 (Fig. 2). At a lower level of identity, the regions common to all four plasmids included the Tra1, Tra2, and replication regions (Fig. 2), which might define the general backbone for IncH plasmids. Future sequencing studies involving other IncH plasmids will surely increase our understanding of their evolution and host range.

Antimicrobial resistance encoded by pAPEC-O1-R. pAPEC-O1-R was found to contain genes encoding resistance to eight different antimicrobial agents (Table 1); some of these genes were located within a class 1 integron (1). When pAPEC-O1-R was transferred into E. coli DH5{alpha}, the transconjugant acquired the ability to resist streptomycin, tetracycline, gentamicin, sulfisoxazole, potassium tellurite, silver nitrate, copper sulfate, and benzylkonium chloride. Recent attention has been given to the possibility that the E. coli isolates of production animals serve as reservoirs of drug resistance for humans (17). Several derivatives of the antimicrobial compounds described above are currently approved for use as growth promoters and/or for the prevention of disease in the U.S. layer and broiler industries (12). Thus, opportunities exist for the selection of multidrug-resistant APEC, such as APEC O1 and APEC O2, and producers should take caution before they use such drugs (9, 10, 11).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Summary of antimicrobial resistances encoded by pAPEC-O1-R

 
Prevalence of pAPEC-O1-R-related genes among ExPEC and commensal E. coli. Multiplex PCR was performed to determine the prevalence of pAPEC-O1-R-associated resistance genes and the RepHI2 replicon among APEC, human uropathogenic E. coli (UPEC), and human and avian commensal E. coli populations (Tables 1 and 2). The results are presented in Table 3. The genes of the pAPEC-O1-R resistance region and the IncHI2 replicon occurred infrequently or rarely among the extraintestinal and commensal E. coli isolates tested. These findings are supported by the findings in the literature. That is, while IncH plasmids appear to occur among Salmonella, Klebsiella, and Serratia species, they have been found infrequently among E. coli isolates (2, 3, 7). The low rate of occurrence of these plasmids among E. coli isolates, the differential codon usage from that of the host, and other genetic differences between pAPEC-O1-R and its host E. coli chromosome suggest that this plasmid was likely acquired from another source. One potential source for such plasmids is the chicken gut, as it is thought that APEC strains that cause disease in poultry originate from the fecal flora (4). Evidence exists for the conjugal transfer of R plasmids in the chicken gut, and the implications of the gut as a "mixing vessel" which facilitates horizontal gene transfer merits further attention.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Primers used in this studya

 

View this table:
[in this window]
[in a new window]
  		TABLE 3. Occurrence of pAPEC-O1-R-associated genes among APEC, UPEC, avian commensal E. coli, and human commensal E. coli isolates

 
In sum, this study presents the complete sequence of an IncHI2 plasmid that occurs among APEC isolates. pAPEC-O1-R encodes resistance to antibiotics and heavy metals, possesses a class 1 integron, and is transferable to plasmidless strains of E. coli. This plasmid shares remarkable similarities with an IncHI2 plasmid from S. marcescens, and comparative genomics between these and other IncH plasmids make it possible to define IncH plasmid backbone components and provide insight into the likely evolutionary development of these plasmids. The sequence of pAPEC-O1-R, along with that of another APEC R plasmid, pAPEC-O2-R, illustrates the potential impact that these transferable, multidrug resistance-encoding plasmids have within the poultry environment.

Nucleotide sequence accession number. The complete, annotated sequence of pAPEC-O1-R is deposited in GenBank under accession number DQ517526.


   ACKNOWLEDGMENTS
 
This project was funded, in part, by the Roy J. Carver Charitable Trust; the Alliance for the Prudent Use of Antibiotics; and Iowa State University's Biotechnology Council, Provost's Office, and College of Veterinary Medicine Dean's Office.

We thank Anne Summers from the University of Georgia for sharing the techniques used for the metal resistance assay.


   FOOTNOTES
 
* Corresponding author. Mailing address: Department of Veterinary Microbiology and Preventive Medicine, College of Veterinary Medicine, 1802 Elwood Drive, VMRI 2, Iowa State University, Ames, IA 50011. Phone: (515) 294-3470. Fax: (515) 294-3839. E-mail: lknolan{at}iastate.edu. Back

{dagger} Supplemental material for this article may be found at http://aac.asm.org/. Back

{triangledown} Published ahead of print on 28 August 2006. Back


   REFERENCES
Top
 Abstract
 Text
 References
 

  1. Bass, L., C. A. Liebert, M. D. Lee, A. O. Summers, D. G. White, S. G. Thayer, and J. J. Maurer. 1999. Incidence and characterization of integrons, genetic elements mediating multiple-drug resistance, in avian Escherichia coli. Antimicrob. Agents Chemother. 43:2925-2929.[Abstract/Free Full Text]
  2. Cavazza, M. E., I. Perez Sechaell, and V. Rodriguez Lemoine. 1991. pUCV11001, an IncH plasmid isolated in a Escherichia coli strain from a healthy child. Acta Cient. Venez. 42:330-334.[Medline]
  3. Chaslus-Dancla, E., and J. P. Lafont. 1985. IncH plasmids in Escherichia coli isolated from broiler chicken carcasses. Appl. Environ. Microbiol. 49:1016-1018.[Abstract/Free Full Text]
  4. Dho-Moulin, M., and J. M. Fairbrother. 1999. Avian pathogenic Escherichia coli (APEC). Vet. Res. 30:299-316.[Medline]
  5. Frost, L. S., R. Leplae, A. O. Summers, and A. Toussaint. 2005. Mobile genetic elements: the agents of open source evolution. Nat. Rev. Microbiol. 3:722-732.[CrossRef][Medline]
  6. Gilmour, M. W., N. R. Thomson, M. Sanders, J. Parkhill, and D. E. Taylor. 2004. The complete nucleotide sequence of the resistance plasmid R478: defining the backbone components of incompatibility group H conjugative plasmids through comparative genomics. Plasmid 52:182-202.[CrossRef][Medline]
  7. Gupta, A., L. T. Phung, D. E. Taylor, and S. Silver. 2001. Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology 147:3393-3402.[Abstract/Free Full Text]
  8. Johnson, T. J., K. E. Siek, S. J. Johnson, and L. K. Nolan. 2005. DNA sequence and comparative genomics of pAPEC-O2-R, an avian pathogenic Escherichia coli transmissible R plasmid. Antimicrob. Agents Chemother. 49:4681-4688.[Abstract/Free Full Text]
  9. Johnson, T. J., K. E. Rodriguez-Siek, S. J. Johnson, and L. K. Nolan. 2006. DNA sequence of a ColV plasmid and prevalence of selected plasmid-encoded virulence genes among avian Escherichia coli. J. Bacteriol. 188:745-758.[Abstract/Free Full Text]
  10. Johnson, T. J., S. J. Johnson, and L. K. Nolan. 2006. Complete DNA sequence of a ColBM plasmid from avian pathogenic Escherichia coli suggests that it evolved from closely related ColV virulence plasmids. J. Bacteriol. 188:5975-5983.[Abstract/Free Full Text]
  11. Medeiros, A. A., and T. F. O'Brien. 1969. Contribution of R factors to the antibiotic resistance of hospital isolates of Serratia. Antimicrob. Agents Chemother. 8:30-35.
  12. Miller Publishing Company. 2005. Feed additive compendium, April, vol. 42, no. 10. Miller Publishing Company, Minnetonka, Minn.
  13. Parkhill, J., G. Dougan, K. D. James, N. R. Thomson, D. Pickard, J. Wain, C. Churcher, K. L. Mungall, S. D. Bentley, M. T. Holden, M. Sebaihia, S. Baker, D. Basham, K. Brooks, T. Chillingworth, P. Connerton, A. Cronin, P. Davis, R. M. Davies, L. Dowd, N. White, J. Farrar, T. Feltwell, N. Hamlin, A. Haque, T. T. Hien, S. Holroyd, K. Jagels, A. Krogh, T. S. Larson, S. Leather, S. Moule, P. O'Gaora, C. Parry, M. Quail, K. Rutherford, M. Simmonds, J. Skelton, K. Stevens, S. Whitehead, and B. G. Barrel. 2001. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413:848-852.[CrossRef][Medline]
  14. Russo, T. A., and J. R. Johnson. 2000. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181:1753-1754.[CrossRef][Medline]
  15. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  16. Sherburne, C. K., T. D. Lawley, M. W. Gilmour, F. R. Blattner, V. Burland, E. Grotbeck, D. J. Rose, and D. E. Taylor. 2000. The complete DNA sequence and analysis of R27, a large IncHI plasmid from Salmonella typhi that is temperature sensitive for transfer. Nucleic Acids Res. 28:2177-2186.[Abstract/Free Full Text]
  17. Singer, R. S., R. Finch, H. C. Wegener, R. Bywater, J. Walters, and M. Lipstich. 2003. Antibiotic resistance—the interplay between antibiotic use in animals and human beings. Lancet Infect. Dis. 3:47-51.[CrossRef][Medline]

Antimicrobial Agents and Chemotherapy, November 2006, p. 3929-3933, Vol. 50, No. 11
0066-4804/06/$08.00+0     doi:10.1128/AAC.00569-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Other Versions of this Article:
AAC.00569-06v1
50/11/3929    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, T. J.
Right arrow Articles by Nolan, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, T. J.
Right arrow Articles by Nolan, L. K.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS